Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

VITA 34 AG

VTIAF
Current price
5.99 USD 0 USD (0.00%)
Last closed 4.52 EUR
ISIN DE000A0BL849
Sector Healthcare
Industry Medical Care Facilities
Exchange XETRA
Capitalization 82 409 668 EUR
Yield for 12 month -4.60 %
1Y
3Y
5Y
10Y
15Y
VTIAF
21.11.2021 - 28.11.2021

VITA 34 AG engages in the collection, processing, cryopreservation, and storage of stem cells from umbilical cord blood and tissue and postnatal tissue in Germany, Poland, Portugal, and internationally. It operates through Subgroup Vita 34 And Subgroup PBKM segments. The company produces and develops advanced therapies, genetic tests, and analyses for third parties. It also develops products and drugs based on cells, tissues, and blood for medical applications; and produces and manufactures viral vectors and CAR-T cells. In addition, the company provides biobanking services, such as freezing sperm and storage of adipose tissue and the isolation of cells from the stored materials. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany. Address: Deutscher Platz 5a, Leipzig, Germany, 04103

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

5.41 EUR

P/E ratio

474

Dividend Yield

Current Year

+76 859 558 EUR

Last Year

+68 758 895 EUR

Current Quarter

+18 508 251 EUR

Last Quarter

+20 326 462 EUR

Current Year

+26 532 117 EUR

Last Year

+2 727 815 EUR

Current Quarter

+6 944 709 EUR

Last Quarter

+6 864 918 EUR

Key Figures VTIAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 3 822 931 EUR
Operating Margin TTM -5.51 %
PE Ratio 474
Return On Assets TTM -0.82 %
PEG Ratio
Return On Equity TTM -1.04 %
Wall Street Target Price 5.41 EUR
Revenue TTM 78 615 932 EUR
Book Value 1.32 EUR
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 6 %
Dividend Yield
Gross Profit TTM 12 405 325 EUR
Earnings per share 0.01 EUR
Diluted Eps TTM 0.01 EUR
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY -6.7 %
Profit Margin -0.12 %

Dividend Analytics VTIAF

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

48 %

Dividend History VTIAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 05.06.2019
Forward Annual Dividend Yield
Last Split Factor 1481:1440
Payout Ratio
Last Split Date 14.07.2017
Dividend Date

Stock Valuation VTIAF

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 474
Forward PE
Enterprise Value Revenue 1.0884
Price Sales TTM 1.0483
Enterprise Value EBITDA 12.2148
Price Book MRQ 3.5036

Financials VTIAF

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators VTIAF

For 52 weeks

3.68 EUR 5.88 EUR
50 Day MA 4.46 EUR
Shares Short Prior Month
200 Day MA 4.71 EUR
Short Ratio
Shares Short
Short Percent

Dynamics of changes in the value of assets

1

1502

2.18 HKD Financial Street Property Co Ltd -0 (-0.46%)
Detailed analytics
F

FTCO

4.32 USD Fortitude Gold Corp -0.08 (-1.82%)
Detailed analytics
C

CBSTF

0.22 USD The Cannabist Company Holdings Inc. -0.02 (-6.74%)
Detailed analytics
P

POFCF

0.20 USD Petrofac Ltd 0 (0%)
Detailed analytics
4

4575

864.00 JPY CanBas Co Ltd -0.31 (-4.95%)
Detailed analytics